🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Vitiligo is an acquired depigmentation disorder of great cosmetic importanc...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01202513
Treatments Being Tested
This purpose of this study is to access the efficacy, tolerability and safe...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-01
Trial ID
NCT00846989
Treatments Being Tested
The purpose of this study to evaluate changes in comfort and dryness in sym...
Status
Completed
Location
Centre for Ocular Research & Education
Start Date
2021-07-07
Trial ID
NCT04297618
Treatments Being Tested
Study of T-PRED(TM) Compared to Pred Forte(R)...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2009-02
Trial ID
NCT00854061
Treatments Being Tested
Efficacy study of Bromfenac Ophthalmic Solution in cataract surgery...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2009-02
Trial ID
NCT00853970
Treatments Being Tested
The primary objective of this study is to compare the safety and efficacy o...
Status
Completed
Location
Alcon Call Center
Start Date
2003-01
Trial ID
NCT00061529
Treatments Being Tested
Efficacy and safety study of bepotastine besilate ophthalmic solution in al...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2007-10
Trial ID
NCT00586664
A dose ranging study to evaluate safety and efficacy of bromfenac ophthalmi...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2010-09
Trial ID
NCT01212471
Treatments Being Tested
The purpose of this study was to assess the efficacy and tolerability of ch...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01327599
Treatments Being Tested
This study will evaluate the long-term safety of bimatoprost 0.01% ophthalm...
Status
Completed
Location
UZ Leuven
Start Date
2011-05-31
Trial ID
NCT01298700
Treatments Being Tested